UK Biologics Market Size, Growth Analysis Report, Forecast to 2027

UK biologics market is estimated to grow at a CAGR of 7.8% during the forecast period. Rising cancer incidences and significant trend towards cell and gene therapy are some key factors accelerating the market growth. As per the World Health Organization (WHO), in 2020, the new cancer incidences which is expected to be reported will be 457,960. This is driving the adoption of biologics drugs serves as an immune system substance that supports to enhance the body’s ability to fight against cancer.

Get Free Sample Copy @ https://www.omrglobal.com/request-sample/uk-biologics-market

 Types of biological drugs comprise vaccines, allergens, blood, tissues, recombinant proteins, blood components, cells, and genes. Biologic products may comprise genes that control the development of vital proteins. These proteins support to control the action of other proteins and cellular processes, cells, or modified human hormones, that develop substances that activate or suppress components of the immune system. 

A Full Report of UK Biologics Market is Available at:  https://www.omrglobal.com/industry-reports/uk-biologics-market

UK biologics market is segmented based on product and application. Based on the product, the market is segmented into antibody therapeutics, vaccines, cell therapy, gene therapy, and others. Increasing focus on approvals of gene therapies is driving the growth of the market. COVID-19 pandemic has accelerated the development of antibody therapeutics in the country. In June 2020, AstraZeneca granted support from the US government which is intended to progress the development of antibody-based COVID-19 therapeutics. The company accelerating efforts beyond its potential vaccine to combat the COVID-19. Based on application, the market is segmented into cancer, autoimmune diseases, infectious diseases, and others. 

UK Biologics Market -- Segmentation

UK Biologics Market by Product

• Antibody Therapeutics
• Vaccines         
• Cell Therapy
• Gene Therapy
• Others

UK Biologics Market by Application

• Cancer
• Autoimmune Diseases
• Infectious Diseases
• Others

UK Biologics Market  – Segment by Region 

North America           

• United States 
• Canada

Europe

• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe

Asia-Pacific    

• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East and Africa

Company Profiles

• AbbVie, Inc.
• Overview
• Product Portfolio 
• Recent Activities
• Amgen, Inc.
• AstraZeneca plc
• Biocon Ltd.
• Boehringer Ingelheim GmbH
• Bristol Myers Squibb Co.
• Eli Lilly and Co.
• F. Hoffman-La Roche AG
• GlaxoSmithKline plc
• Smith & Nephew PLC

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/uk-biologics-market

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com 
Contact no: +1 646-755-7667, +91 780-304-0404